CORTLANDT MANOR, N.Y., April 11 Polymedco, Inc. is pleasedto announce the introduction of the PATHFAST immunoassay analyzer. ThePATHFAST rapid point of care system utilizes a chemiluminescent ...

CORTLANDT MANOR, N.Y., June 21, 2016 /PRNewswire/ -- Polymedco announced today that its OC-Auto® family of FIT products and Epi proColon® (Epigenomics) blood test for colorectal cancer screening have ...

Annual FIT-based screening produced fewer CRC cases, fewer CRC deaths and more life years gained versus all other strategies, even at real-world adherence rates. Every screening strategy that was ...

Polymedco, a manufacturer, marketer and distributor in the clinical laboratory space, has pledged support to the Colon Cancer Prevention Project, based in Louisville, Ky. Polymedco will lend support ...

SANTA BARBARA, CA / ACCESSWIRE / August 14, 2015 / As health plans and accountable care organizations (ACOs) across the United States review their colorectal cancer (CRC) screening practices, many of ...

LAKE FOREST, Ill., June 6, 2022 /PRNewswire/ -- RoundTable Healthcare Partners ("RoundTable"), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today ...

Epigenomics AG has announced that Polymedco, Inc. reiterates its commitment to support Epi proColon(R) in the United States. Epi proColon(R) is Epigenomics' convenient blood-based test for colorectal ...

CORTLANDT MANOR, N.Y., Jan. 30, 2024 /PRNewswire/ -- Polymedco, a leading provider of best-in-class colorectal cancer screening and early detection solutions, is proud to announce its membership in ...

Phenomenome Discoveries Inc. and Polymedco Cancer Diagnostic Products LLC. have announced a commercial licensing agreement for the US market, providing rights to Polymedco to commercialize PDI’s ...

Screening annually with a method like OC-Auto FIT improves outcomes and delivers greater cost-effectiveness. Post thi Annual FIT-based screening produced fewer CRC cases, fewer CRC deaths and more ...